That is essential, since the method a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we need to understand how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error process (exponential tech investor). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're created to do. This was a breakthrough nearly nobody observed. However it's going to have extensive ramifications for curing disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be lots of financial investment chances in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (united arab emirates). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it drew back maybe considerably prior to going greater - first lady. I've been covering bitcoin for a long period of time now. Among the very first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were mostly educating readers. But that's not the big question any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. jeff brown 2020 predictions. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are many fantastic personal business on the brink of striking the public markets And I have actually been dealing with a new method for you to invest even before these business go public.
This chance has been constructing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to schedule your area for complimentary.
Emma Walsh here, handling editor of the Diary. Routine Journal readers know that tech isn't our normal beat (jeff brown genome sequencing stock). And when it comes to tech investing, we leave it to the specialists. Thankfully, we have several such specialists in our Rolodex. Our coworker Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing specialists we know (last year). In reality, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the huge image and anticipate what's simply around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and a lot more. These trends are experiencing rapid growth and creating amazing chances for investors. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. jeff brown predictions for 2021. But despite what lots of readers might think, this is a trend that's simply getting begun. Although the COVID-19 pandemic interrupted supply chains last year, an outstanding 250 million 5G-enabled gadgets were still sold.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (angel investor). Losing 2 months of production and sales really impacts how lots of 5G gadgets are sold in the calendar year. When you consider all of that, selling 250 million units is exceptional. More significantly, the delays triggered by the pandemic created a lots of pent-up need. And that need is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G devices will be shipped in 2021 - jeff brown top biotech stock 2021. And that's not my only 5G prediction When I've discussed 5G in the past, I have actually described its three various stages.
In Phase 2, 5G devices go on sale. 5G phones and other items begin to reach customers. And in Phase 3, 5G services start to be offered (legacy report prediction). That's when we start to see applications running on 5G networks. Think about things like enormous multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase Three by this summer. This begins something of a virtuous cycle: The majority of individuals do not really care about the technology. But they will care if there are exciting applications that can just be accessed with a 5G phone.
That results in more 5G apps being developed. In fact, 5G is going to open up a suite of amazing applications: self-driving vehicles, the Internet of Things, robotic surgical treatment, and more. All of these innovations need 5G. The investment opportunities moving forward will be massive. Stepping far from 5G, the next important technology I anticipate in 2021 is CRISPR hereditary modifying. CRISPR represents "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it is among the most exciting advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not function correctly. CRISPR utilizes a comparable idea however with our hereditary code. "Typos" in our genome can lead to disease. CRISPR can correct these "typos." For several years, CRISPR was primarily a specific niche innovation that wasn't well understood. And throughout that time, there were actually only 3 business operating in this area. But things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're dealing with illness and seeing that this technology simply works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and providing incredible returns. This entire industry is successfully a greenfield opportunity.
There's room for many companies to exist in this space. first lady. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or 3 more hereditary modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things happening at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software application can properly anticipate the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is very important due to the fact that the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be effective.
Historically, this has actually been an experimental process. And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're developed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but several drug therapies produced using this innovation. This was among those advancements that almost no one observed. But it's going to have extensive ramifications for curing illness. And, obviously, there will be a lot of financial investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it pulled back perhaps considerably before going greater. I have actually been covering bitcoin for a long time now. Among the first research study reports I ever released was on bitcoin - first lady. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. But at the time of that preliminary suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
However nobody is asking that concern anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. jeff bezos. Mass, Mutual is a 150-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the details is up to date since February 2021, but we could not separately validate this claim. Provided Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like capability to select winning innovation stocks. He spent more than 25 years researching innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an exceptional point of view on the market. He's always on the hunt for new opportunities, and he shares much of his finest picks in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he successfully anticipated a few of the greatest economic events of the past 20 years. Although he does not appear to launch his choices to the public, the service's success is a direct sign of Brown's stock-picking expertise. No one on Wall Street gets it right every time, but Jeff Brown's precise predictions have earned him legions of devoted fans. That states a lot about his ability. The Near Future Report is published by Brownstone Research study, a popular financial research study publisher. Brownstone Research study offers several research study services with a wide array of specializations - exponential growth.
The company is likewise connected with Bonner & Partners, another well-respected research publisher - genetic sequencing companies jeff brown. On its site, Brownstone states its objective is to supply retail financiers with professional-grade research: "For too long, the very best investment research study has not been offered to specific financiers. It has been typically reserved for investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown prediction for 2021. The mission of Brownstone Research is to make that kind of exclusive research study offered to any investors aiming to get an edge in the marketplaces. The objective is easy to provide special and lucrative financial investment research study discovered nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research, and he also works as the company's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After years of constant success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you know even a bit about the market, you understand that he has a credibility as a King Midas of sorts. artificial intelligence. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown thinks S.A.V. exponential tech investor. might be "the biggest pattern of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be marrying 2 innovative innovations: expert system and electric automobiles. Musk hopes the mix will help him develop the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing brief of the vehicle industry's Holy Grail. As you know, electric cars and self-driving car stocks have been substantial this year, however the Wall Street machine has actually approved buzz without much concrete outcome. In spite of a drastic boost in competitors over the past couple of years, Brown still thinks Musk has the finest opportunity of putting it all together.
tech could be the magic string that ties it all together. S.A.V. means Shared Autonomous Car, and it could be the future of transport. Essentially, this innovation would enable you to lease your automobile as a self-governing, self-driving taxi when you're not utilizing it. You merely get out of the automobile and press a button on an app that tells the automobile to "sign up with the fleet." Next thing you understand, you're unwinding on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a large piece of the earnings. It sounds crazy, but it could be closed than you think.